Clinical Trial Update: Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing denosumab to placebo in men with osteoporosis has completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Bone Mass
• Low Bone Mineral Density
• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Low Bone Mass, Low Bone Mineral Density | Phase 3 | Status: COMPLETED | Results posted: 2012-11-29